Milestone Pharmaceuticals Inc
MIST1.760USD
+0.040+2.33%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
149.90M시가총액
손실P/E TTM
자세한 내용은 Milestone Pharmaceuticals Inc 회사
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc 정보
종목 코드 MIST
회사 이름Milestone Pharmaceuticals Inc
상장일May 09, 2019
CEOOliveto (Joseph)
직원 수33
유형Ordinary Share
회계 연도 종료May 09
주소420-1111 boul. Dr.-Frederik-Philips
도시MONTREAL
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Canada
우편 번호H4M 2X6
전화15143360444
웹사이트https://www.milestonepharma.com
종목 코드 MIST
상장일May 09, 2019
CEOOliveto (Joseph)
Milestone Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
128.30K
+7855.00%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
119.05K
+7855.00%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
+50000.00%
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
--
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Mr. Jeffrey Nelson
Mr. Jeffrey Nelson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
128.30K
+7855.00%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
119.05K
+7855.00%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
+50000.00%
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
--
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Simplify Asset Management Inc
9.34%
Adage Capital Management, L.P.
8.19%
Propel Bio Management, LLC
6.02%
Trails Edge Capital Partners LP
4.50%
OrbiMed Advisors, LLC
3.78%
기타
68.16%
주주
주주
비율
Simplify Asset Management Inc
9.34%
Adage Capital Management, L.P.
8.19%
Propel Bio Management, LLC
6.02%
Trails Edge Capital Partners LP
4.50%
OrbiMed Advisors, LLC
3.78%
기타
68.16%
주주 유형
주주
비율
Investment Advisor
16.52%
Hedge Fund
14.43%
Venture Capital
6.24%
Research Firm
5.04%
Individual Investor
3.97%
Investment Advisor/Hedge Fund
3.95%
Private Equity
3.78%
Family Office
1.17%
Bank and Trust
0.02%
기타
44.87%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
118
42.48M
49.88%
+14.49M
2025Q3
99
19.38M
22.80%
-5.64M
2025Q2
99
14.54M
18.86%
-15.65M
2025Q1
102
12.26M
22.94%
-17.24M
2024Q4
99
25.17M
47.19%
-9.38M
2024Q3
113
29.31M
55.02%
-13.44M
2024Q2
115
30.81M
57.87%
-11.80M
2024Q1
116
31.96M
60.43%
+3.19M
2023Q4
112
18.49M
55.02%
-13.59M
2023Q3
109
20.24M
60.32%
-12.06M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Simplify Asset Management Inc
7.96M
9.34%
+5.18M
+186.09%
Sep 30, 2025
Adage Capital Management, L.P.
6.98M
8.19%
+6.98M
--
Sep 30, 2025
Propel Bio Management, LLC
5.12M
6.02%
+4.27M
+502.93%
Jul 11, 2025
Trails Edge Capital Partners LP
3.83M
4.5%
-1.50M
-28.13%
Sep 30, 2025
OrbiMed Advisors, LLC
3.22M
3.78%
+3.22M
--
Sep 30, 2025
Oliveto (Joseph Gerard)
2.51M
2.95%
+66.67K
+2.73%
Jul 11, 2025
Morgan Stanley & Co. LLC
2.63M
3.09%
+1.81M
+221.87%
Sep 30, 2025
RTW Investments L.P.
2.51M
2.94%
--
--
Sep 30, 2025
Pathstone
1.00M
1.17%
+1.00M
--
Sep 30, 2025
Two Sigma Investments, LP
900.59K
1.06%
+900.59K
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
Simplify Propel Opportunities ETF
8.04%
SPDR S&P International Small Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
Simplify Propel Opportunities ETF
비율8.04%
SPDR S&P International Small Cap ETF
비율0.01%
Avantis US Small Cap Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
